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Background:  Adipose  tissue  is  the  source  of  many  adipokines  affecting  the  cardiovascular  system  either
locally  or  systemically.  Although  hypertension  is one  of  the  most  important  factors  in  diastolic  dys-
function  (DD),  the  exact  cause  of  this  relationship  is unknown.  There  is  no speciﬁc  study  in  the  current
literature  regarding  the  association  of  epicardial  adipose  tissue  (EAT)  with  left  ventricular  DD  in patients
with essential  hypertension.
Methods: The  present  study  was  cross-sectional  and observational,  including  127  patients  with  untreated
hypertension  who  underwent  a complete  transthoracic  echocardiographic  examination  as  well  as  mea-
surements  of  EAT  and  diastolic  parameters.
Results:  EAT  was  signiﬁcantly  correlated  with  left atrial  dimension,  DD  parameters,  and  left ventricular
(LV)  mass  as  well  as age  and  blood  pressure  measurements.  EAT was  also  correlated  with  Framingham  risk
score (p  <  0.001).  Age  and  EAT  were  signiﬁcantly  increased  in patients  with  high grades  of  DD  compared
to  those  with  low  values  (p  < 0.001  and  p =  0.001,  respectively).  Linear  regression  analyses  revealed  EAT
as an  independent  predictor  of all DD parameters.  The  area  under  the  curve  values  of  EAT were  similar
to  age  and higher  than those  of  LV mass  and mean  BP  for both  the  presence  of DD and  grade  two  DD.
Conclusion:  Based  on  our  ﬁndings,  increased  EAT  may  be  associated  with  diastolic  dysfunction  and  left
atrial dilatation  due  to  local  or systemic  effects  in untreated  hypertensive  patients.  This  relationship  is
independent  of  and  stronger  than  abdominal  obesity,  implicating  the  clinical  importance  of  measuring
EAT  thickness.
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Evaluation of diastolic function in every patient undergoing
chocardiography is important clinically [1]. Diastolic dysfunction,
s seen in patients with hypertension (HT), diabetes mellitus, and
geing, increases the risk of heart failure and cardiovascular mortal-
ty, even if in at an asymptomatic or preclinical stage [2]. Although
dentiﬁable by Doppler echocardiography, there is no deﬁnitive
reatment for diastolic dysfunction. Pathophysiological research
mplicates an active ﬁbrotic process, which might lead to new ther-
peutic options in future [3,4].
Obesity is one of the most important features of diastolic dys-
unction. Adipose tissue is the source of many adipokines affecting
he cardiovascular system either locally or systemically [5]. Fat,
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mainly accumulated in subcutaneous tissue, is also deposited
around visceral organs in the abdominal or thoracic region [6]. Fat is
accumulated in three different localizations around the heart: cel-
lular, epicardial, and pericardial. Epicardial fat is located between
myocardium and visceral layer of pericardium. Pericardial fat is
located between the visceral and parietal layers of pericardium [7].
Epicardial adipose tissue (EAT) thickness measured by echocardi-
ography has a good correlation with abdominal adiposity measured
by computed tomography (CT) and magnetic resonance imaging
(MRI) [8,9]. Konishi et al. demonstrated a signiﬁcant correlation
between pericardial fat and diastolic dysfunction in patients with
normal systolic function [10].
Although HT is one of the most important factors in diastolic dys-
function, the exact cause of this relationship is still unknown [11].
An increased epicardial fat mass may  deteriorate cardiac function
either locally or systemically by passive or active effects. There is
no speciﬁc study in the current literature regarding the association
of EAT with left ventricular diastolic dysfunction in patients with
essential HT. Therefore, we  planned this study in order to clarify
this relation.
vier Ltd. All rights reserved.
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atient population and study protocol
The present study was cross-sectional and observational,
ncluding 127 patients with untreated HT who underwent a
omplete transthoracic echocardiographic examination as well as
easurements of EAT and diastolic parameters. All data were
rospectively collected. Resting blood pressure (BP) values were
btained at a physician’s ofﬁce and echocardiography room by tra-
itional auscultatory method using a sphygmomanometer. Patients
ere advised to refrain from smoking or consumption of coffee or
ea, and physical exercise, 30 min  prior to the measurement. Before
easurement, patients were seated to rest for 5 min. Two  separate
easurements were averaged to determine ofﬁce blood pressure.
Patients with previous coronary artery disease (CAD)
17 patients), diabetes mellitus (20 patients), left ventricular
ystolic dysfunction (14 patients), secondary HT (2 patients, renal
rtery stenosis), moderate-severe valve disease (15 patients;
0 aortic stenosis, 5 mitral insufﬁciency), atrial ﬁbrillation (18
atients), symptoms of CAD and equivalent ﬁndings on exercise
lectrocardiography and perfusion scan, or 24-h rhythm electro-
ardiography (20 patients; 15 positive exercise tests and 5 positive
ingle photon emission computed tomography scans), and patients
reviously treated for HT (22 patients) were excluded.
Baseline characteristics of the patients were recorded. HT
as deﬁned as the documentation of blood pressure more than
40/90 mmHg. Patients who were using tobacco products on
dmission and those who had quit smoking within the last year
ere considered as smokers.
The study was performed in accordance with the principles
tated in the Declaration of Helsinki and approved by the local
thics committee.
outine measurements
Blood samples were drawn by venipuncture to measure routine
lood chemistry parameters after fasting for at least 8 h. Fasting
lood glucose, serum creatinine, total cholesterol, high-density
ipoprotein cholesterol, low-density lipoprotein cholesterol, and
riglyceride levels were recorded. Glucose, creatinine, and lipid
ig. 1. Measurement of epicardial fat thickness by echocardiography. EAT, identiﬁed as
arasternal long-axis view on 2-dimensional echocardiography, was measured perpendi
A,  left atrium; RV, right ventricle; Ao, aorta.logy 61 (2013) 359–364
proﬁle were determined by standard methods. Serum C-reactive
protein (CRP) was  analyzed using a nephelometric technique
(Beckman Coulter Image 800, Fullerton, CA, USA; normal range
0–0.8 mg/dL). Body mass index (BMI) was  determined by the fol-
lowing formula: BMI  = weight (kg)/height2 (m).
Echocardiography
Patients were imaged in the left lateral decubitus position with
commercially available systems with a GE-Vingmed Vivid S5 (GE-
Vingmed Ultrasound AS, Horten, Norway) using a 2.5–3.5 MHz
transducer. Diastolic parameters were measured according to
guidelines by the American Society of Echocardiography [1]. Early
(E) and late mitral inﬂow (A) velocities, lateral and medial mitral
annular velocities (Em, Am), isovolumic relaxation time (IVRT), iso-
volumic contraction time (IVCT), ejection time (ET), deceleration
time (DT), and Tei index (also known as myocardial performance
index) [MPI = (IVRT + IVCT)/ET] were calculated according to rele-
vant guidelines [1]. Left ventricular ejection fraction was measured
by Simpson’s method [12]. Maximum and minimum left atrial
(LA) volumes were measured by the method of discs from the
apical four-chamber view at end-systole and end-diastole [13].
End-systolic measurements were obtained from the frame preced-
ing mitral valve opening.
Left ventricular mass (LV mass, in g) was calculated according to
the following formula: 1.04 × [(LVEDD + IVSD + PWD)3 − LVEDD3]
− 13.6 (diameter in cm)  [14], where LVEDD = left ventricular end-
diastolic dimension; IVSD, interventricular septal thickness at
diastole; PWD, posterior wall thickness at diastole.
Evaluation of epicardial adipose tissue
EAT was  evaluated on the free wall of right ventricle from the
parasternal long-axis view, using aortic annulus as an anatomic
reference (Fig. 1). We preferred the area above the right ventricle
to measure EAT thickness, because this area is known to have the
thickest EAT layer. EAT, identiﬁed as an echo-free space between
the visceral pericardial layer and myocardium on 2-dimensional
echocardiography, was measured perpendicularly in front of the
right ventricular free wall at end-diastole [8,15]. We  magniﬁed
each still image for better visualization and accurate measurement
 an echo-free space between the myocardium and visceral pericardium from the
cularly in front of the right ventricular free wall at end-diastole. LV, left ventricle;
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f EAT thickness and measured the thickest point of EAT in each
ycle. To standardize the measuring axis, we used the aortic annu-
us as anatomical reference. The measurement was  performed at a
oint on the free wall of the right ventricle along the midline of the
ltrasound beam, perpendicular to the aortic annulus. The average
alue comprising three cardiac cycles of each echocardiographical
iew was used for the statistical analysis. EAT measurements were
erformed by a second reader to prevent a possible bias between
AT and extensive echocardiographic measurements. The intra-
bserver mean absolute difference in measurements of EAT was
.3 ± 0.4 mm (coefﬁcient of variation: 1.6%, intra-class correlation:
.95).
tatistical analysisContinuous variables were given as mean ± standard deviation;
ategorical variables were deﬁned as percentages. Data were tested
or normal distribution using the Kolmogorov–Smirnov test. The 2
able 1
aseline characteristics of the study population.
Parameters (N = 127) Epicardial fat pad thickness 
<5 mm (36) 5–7
Age (years) 44 ± 7 50 
Gender (male) 67% 67%
BMI  (kg/m2) 28.8 ± 3.4 30.
Waist  circumference (cm) 97.2 ± 9.6 101
Smoking 48% 42%
Hyperlipidemia 35% 38%
Glucose (mg/dL) 93 ± 12 99 
Creatinine (mg/dL) 0.86 ± 0.23 0.8
Total  cholesterol (mg/dL) 205 ± 44 219
LDL  (mg/dL) 128 ± 35 138
HDL  (mg/dL) 45 ± 14 47 
Triglyceride (mg/dL) 165 ± 89 171
CRP  (mg/dL) 0.38 ± 0.41 0.4
Epicardial fat pad thickness (mm)  4.2 ± 0.8 6.2
Systolic BP (mmHg) 146 ± 17 156
Diastolic BP (mmHg) 92 ± 11 99 
Mean  BP (mmHg) 110 ± 12 118
Echocardiography
Left  ventricular parameters
Ejection fraction (%) 65 ± 4 65 
LVEDD (mm)  45 ± 9 46 
LVESD (mm) 28 ± 4 29 
IVSD  (mm)  11.5 ± 1.3 12.
PWD  (mm)  10.6 ± 1.3 11.
LV  mass (g) 211 ± 69 234
Doppler echocardiography
Mitral E velocity (cm/s) 71 ± 16 70 
Mitral A velocity (cm/s) 73 ± 16 80 
E/A  ratio 1.02 ± 0.34 0.9
DT  (ms) 208 ± 32 230
IVRT  (ms) 82 ± 13 92 
IVCT  (ms) 34 ± 25 29 
LVET  (ms) 271 ± 23 264
MPI  0.42 ± 0.11 0.4
Left  atrial parameters
LA diameter (mm)  34.7 ± 3.3 36.
LA  volume
Maximum 53 ± 12 58 
Minimum 21 ± 6 26 
Tissue Doppler parameters
Sm:  lateral/septal 9.3 ± 1.9/7.9 ± 1.1 10.
Em  (cm/s): lateral/septal 10.6 ± 2.6/8.1 ± 2.4 9.8
Am  (cm/s): lateral/septal 10.1 ± 2.6/9.8 ± 2.3 11.
Em/Am ratio: lateral/septal 1.1 ± 0.5/0.9 ± 0.4 1.0
E/Em  ratio: lateral/septal 6.8 ± 1.7/9.2 ± 2.7 7.6
MI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CRP, C-
VESD, left ventricular end-systolic diameter; IVSD, interventricular septal diameter; PWD
oppler; Am,  late diastolic mitral annular velocity obtained from tissue Doppler; E, early p
elocity  obtained from tissue Doppler; ET, ejection time; DT, deceleration time; IVCT, iso
yocardial performance index; LA, left atrium.logy 61 (2013) 359–364 361
test was  used for the categorical variables among the groups. Mean
values were compared by ANOVA. Linear regression analysis with
Backward method was  used for the multivariate analysis of inde-
pendent variables which were included if they were signiﬁcantly
different in the univariate analyses. All tests of signiﬁcance were
two-tailed. Statistical signiﬁcance was  deﬁned as p < 0.05. The SPSS
statistical software (SPSS 20.0 for Windows, Chicago, IL, USA) was
used for all statistical calculations.
Results
The clinical characteristics of the study population are detailed
in Table 1. Age (p = 0.001), BMI  (p < 0.001), waist circumference
(p < 0.001), CRP (p = 0.002), and blood pressure measurements (sys-
tolic, p < 0.001; diastolic, p = 0.007) were signiﬁcantly higher in the
high EAT group compared to the low EAT group (>7 mm vs. <5 mm).
Left atrial dimension and diastolic dysfunction parameters were
signiﬁcantly higher in patients with increased EAT (Table 1).
p-Value
 mm (42) >7 mm (49)
± 7 50 ± 9 0.001
 66% 0.981
1 ± 3.3 33.6 ± 4.3 <0.001
.6 ± 7.1 111.0 ± 9.1 <0.001
 55% 0.679
 42% 0.797
± 17 99 ± 14 0.096
5 ± 0.13 0.81 ± 0.10 0.146
 ± 35 227 ± 41 0.029
 ± 33 145 ± 36 0.056
± 11 45 ± 9 0.614
 ± 123 186 ± 109 0.611
6 ± 0.42 0.72 ± 0.57 0.002
 ± 0.5 9.3 ± 1.7 <0.001
 ± 13 161 ± 17 <0.001
± 7 99 ± 10 0.007
 ± 8 120 ± 11 <0.001
± 3 64 ± 5 0.068
± 4 47 ± 4 0.380
± 6 30 ± 5 0.299
0 ± 1.8 13.4 ± 2.1 <0.001
3 ± 1.4 12.3 ± 1.6 <0.001
 ± 59 279 ± 82 <0.001
± 18 63 ± 16 0.064
± 18 87 ± 16 0.002
1 ± 0.31 0.74 ± 0.20 <0.001
 ± 58 232 ± 38 0.061
± 18 100 ± 19 0.001
± 40 48 ± 22 0.022
 ± 30 269 ± 28 0.537
8 ± 0.19 0.55 ± 0.14 0.004
3 ± 4.4 39.1 ± 3.4 <0.001
± 16 67 ± 17 0.001
± 10 31 ± 11 0.011
0 ± 2.6/7.9 ± 1.5 8.7 ± 1.7/7.1 ± 1.4 0.015/0.020
 ± 2.9/6.6 ± 1.8 8.6 ± 2.6/6.1 ± 1.4 0.005/<0.001
1 ± 3.0/10.0 ± 2.2 10.5 ± 2.8/9.9 ± 2.1 0.375/0.941
 ± 0.4/0.7 ± 0.2 0.9 ± 0.4/0.6 ± 0.2 0.032/0.001
 ± 2.6/11.0 ± 2.7 8.0 ± 2.5/10.7 ± 2.9 0.162/0.044
reactive protein; BP, blood pressure; LVEDD, left ventricular end-diastolic diameter;
, posterior wall diameter; A, atrial (late) peak mitral velocity obtained from pulsed
eak mitral velocity obtained from pulsed Doppler; Em, early diastolic mitral annular
volumic contraction time; IVRT, isovolumic relaxation time; LV, left ventricle; MPI,
3  Cardiology 61 (2013) 359–364
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Table 4
The relationship of EAT and other study parameters with degree of diastolic
dysfunction.
Parameters Diastolic dysfunction gradea p-Value
Normal Grade I Grade II
Age (years) 41 ± 8 50 ± 8 52 ± 8 <0.001
BMI  (kg/m2) 30 ± 4 32 ± 5 32 ± 4 0.118
Waist circumference (cm) 100 ± 10 106 ± 11 106 ± 10 0.136
EAT (mm)  5.4 ± 1.8 7.2 ± 2.4 7.7 ± 2.3 0.001
LV  mass (g) 213 ± 64 253 ± 79 249 ± 63 0.108
CRP  (mg/dL) 0.36 ± 0.20 0.65 ± 0.54 0.62 ± 0.62 0.208
Mean BP (mmHg) 116 ± 12 114 ± 14 118 ± 9 0.276
BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; LV, left ventricle;
EAT, epicardial adipose tissue.
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EAT signiﬁcantly correlated to left atrial dimension, diastolic
ysfunction parameters, and left ventricular mass (LV mass) as well
s age and BP measurements (Tables 2 and 3). EAT also correlated to
ramingham risk score (p < 0.001). Age and EAT were signiﬁcantly
ncreased in patients with high degrees of diastolic dysfunc-
ion group compared to the low group (p < 0.001 and p = 0.001,
espectively) (Table 4). Linear regression analyses revealed EAT as
n independent predictor of all diastolic dysfunction parameters
Table 5).
The area under the curve values of EAT were similar to age and
igher than those of LV mass and mean BP for both the presence of
iastolic dysfunction and grade two diastolic dysfunction (Table 6).
iscussion
We  have revealed that echocardiographically measured EAT
elated signiﬁcantly to left ventricular diastolic dysfunction and
ncreased left atrial volume, independent of blood pressure, LV
ass, and other risk factors, in a group of patients with essen-
ial hypertension and normal left ventricular systolic function
able 2
orrelations of EAT with Framingham risk score, demographic, metabolic, and
chocardiographic study parameters.
Variables Epicardial fat pad thickness (mm)
Age (years) r = 0.296, p = 0.001
BMI  (kg/m2) r = 0.467, p < 0.001
Waist circumference (cm) r = 0.582, p < 0.001
Mean BP (mmHg) r = 0.374, p < 0.001
Systolic BP (mmHg) r = 0.372, p < 0.001
Diastolic BP (mmHg) r = 0.256, p = 0.009
Metabolic syndrome parameters
CRP (mg/dL) r = 0.435, p < 0.001
Glucose (mg/dL) r = 0.216, p = 0.021
Creatinine (mg/dL) r = 0.045, p = 0.636
Uric acid (mg/dL) r = 0.259, p = 0.008
LDL (mg/dL) r = 0.236, p = 0.003
HDL (mg/dL) r = −0.157, p = 0.108
Triglyceride (mg/dL) r = 0.156, p = 0.053
Echocardiography
LA  diameter (mm)  r = 0.500, p < 0.001
LV mass (g) r = 0.519, p < 0.001
Framingham risk score r = 0.414, p < 0.001
MI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-
ensity lipoprotein; LDL, low-density lipoprotein; LA, left atrium; LV, left ventricle;
AT, epicardial adipose tissue.
able 3
orrelations of diastolic function parameters and LA with EAT and other study parameter
Variables E/A ratio IVRT 
Age (years) r = −0.466, p < 0.001 r = 0.219, p = 0.028 
BMI  (kg/m2) r = −0.153, p = 0.102 r = 0.112, p = 0.269 
Waist  circumference (cm) r = −0.287, p = 0.004 r = 0.228, p = 0.037 
Epicardial fat pad thickness (mm)  r = −0.430, p < 0.001 r = 0.418, p < 0.001 
LV  mass (g) r = −0.302, p = 0.001 r = 0.389, p < 0.001 
CRP  (mg/dL) r = −0.297, p = 0.003 r = 0.076, p = 0.491 
Systolic  BP (mmHg) r = −0.172, p = 0.073 r = −0.021, p = 0.844
Diastolic  BP (mmHg) r = −0.137, p = 0.153 r = 0.176, p = 0.090 
Mean  BP (mmHg) r = −0.160, p = 0.095 r = 0.086, p = 0.409 
Framingham risk score r = −0.473, p < 0.001 r = 0.342, p = 0.001 
Metabolic parameters
Glucose (mg/dL) r = −0.158, p = 0.099 r = 0.056, p = 0.592 
Creatinine (mg/dL) r = −0.131, p = 0.171 r = 0.129, p = 0.216 
Uric  acid (mg/dL) r = −0.018, p = 0.854 r = 0.073, p = 0.486 
HDL  (mg/dL) r = 0.007, p = 0.944 r = −0.194, p = 0.064
LDL  (mg/dL) r = −0.313, p = 0.001 r = −0.063, p = 0.555
Triglyceride (mg/dL) r = −0.045, p = 0.668 r = 0.082, p = 0.467 
MI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-density 
picardial adipose tissue; IVRT, isovolumic relaxation time; MPI, myocardial performancea Diastolic function was graded using echocardiographic Doppler variables des-
ignated as normal, grade I (impaired relaxation pattern), grade II (pseudo-normal
pattern).
without preexisting diabetes mellitus and CAD. To the best of our
knowledge, this is the ﬁrst study documenting this association.
The echocardiographic measurement of EAT, an objective, non-
invasive, readily available, and certainly less expensive measure of
visceral fat than MRI  or CT, offers a more sensitive and speciﬁc index
of true visceral fat content by avoiding the possible confounding
effect of subcutaneous abdominal fat [16].
The embryological source of EAT is similar to abdominal vis-
ceral adiposity [17]. Fat is accumulated in different localizations
around the heart. Pericardial fat is located between the visceral and
parietal layers of pericardium whereas epicardial fat is between
myocardium and visceral layer of pericardium [7]. EAT is a special
fat depot which is related to visceral fat rather than total adiposity
and shares the same microcirculation with myocardial tissue [17].
EAT is located mainly in periaortic, atrioventricular, and interven-
tricular sulcus along with main coronary arteries. Coronary arteries
are embedded within EAT and have the same metabolic milieu.
This adipose tissue envelops tunica intima, media, and adventitia
as tunica adiposa through the entire length of coronary arteries and
all vasculature [18,19].
EAT is a stronger predictor of CAD than visceral adipose tissues
located in other parts of the body [20–22]. Moreover, increased EAT
was associated with poor coronary ﬂow reserve even in patients
with angiographically normal coronary arteries [23,24]. In a recent
study, Mahfouz et al. demonstrated a strong relationship between
impaired endothelial coronary ﬂow reserve and left ventricular dia-
stolic dysfunction [25]. Moreover, Sasaki and coworkers reported a
positive association between coronary blood ﬂow and isovolumic
s.
MPI  DT LA
r = 0.009, p = 0.926 r = 0.382, p < 0.001 r = 0.158, p = 0.083
r = 0.134, p = 0.172 r = −0.042, p = 0.652 r = 0.270, p = 0.003
r = 0.244, p = 0.020 r = 0.137, p = 0.180 r = 0.391, p < 0.001
r = 0.401, p < 0.001 r = 0.291, p = 0.001 r = 0.500, p < 0.001
r = 0.266, p = 0.006 r = 0.224, p = 0.015 r = 0.641, p < 0.001
r = 0.158, p = 0.132 r = 0.080, p = 0.432 r = 0.076, p = 0.446
 r = −0.036, p = 0.719 r = 0.027, p = 0.779 r = 0.273, p = 0.003
r = 0.124, p = 0.215 r = 0.119, p = 0.216 r = 0.269, p = 0.004
r = 0.037, p = 0.714 r = 0.083, p = 0.389 r = 0.303, p = 0.001
r = 0.070, p = 0.504 r = 0.483, p < 0.001 r = 0.404, p < 0.001
r = 0.125, p = 0.214 r = 0.218, p = 0.022 r = 0.105, p = 0.270
r = 0.157, p = 0.118 r = 0.209, p = 0.028 r = 0.108, p = 0.255
r = 0.171, p = 0.092 r = 0.023, p = 0.810 r = 0.126, p = 0.189
 r = −0.123, p = 0.227 r = −0.113, p = 0.242 r = −0.250, p = 0.008
 r = 0.035, p = 0.735 r = 0.179, p = 0.066 r = −0.129, p = 0.180
r = 0.208, p = 0.056 r = 0.034, p = 0.750 r = 0.138, p = 0.181
lipoprotein; LDL, low-density lipoprotein; LA, left atrium; LV, left ventricle; EAT,
 index; DT, deceleration time.
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Table  5
Linear regression analyses were used for prediction of E/A ratio, IVRT, MPI and LA diameter.
Dependent variables E/A ratio IVRT MPI  LA
Independent variables Beta, p value Beta, p value Beta, p value Beta, p value
Age (years) ˇ: −0.362, p < 0.001 – ˇ: −0.195, p = 0.058 –
Epicardial fat pad thickness (mm)  ˇ: −0.332, p < 0.001 ˇ: 0.247, p = 0.045 ˇ: 0.404, p < 0.001 ˇ: 0.195, p = 0.023
LV  mass (g) – ˇ: 0.286, p = 0.021 – ˇ: 0.527, p < 0.001
CRP  (mg/dL) ˇ: −0.169, p = 0.051 – – –
Mean  BP (mmHg) – – – –
BMI, body mass index; CRP, C-reactive protein; EAT, epicardial adipose tissue; BP, blood p
relaxation time; MPI, myocardial performance index.
Table 6
Receiver-operating characteristic curves for the sensitivity and the speciﬁcity of age,
EAT, LV mass, and mean blood pressure to detect the presence of DD and grade 2
DD.
Parameters AUC SE p 95% CI
Presence of DD
Age 0.838 0.052 0.000 0.736–0.940
EAT 0.749 0.066 0.001 0.621–0.878
LV  mass 0.647 0.076 0.058 0.497–0.796
Mean BP 0.515 0.076 0.842 0.366–0.665
Presence of grade 2 DD
Age 0.678 0.054 0.002 0.573–0.784
EAT 0.630 0.057 0.026 0.519–0.741
LV  mass 0.586 0.058 0.139 0.473–0.700
Mean BP 0.580 0.058 0.168 0.468–0.693
AUC, area under the curve; SE, standard error; CI, conﬁdence interval; DD, dia-
stolic dysfunction; BP, blood pressure; LV, left ventricle; EAT, epicardial adipose
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rately.issue; IVRT, isovolumic relaxation time; MPI, myocardial performance index; DT,
eceleration time; DD, diastolic dysfunction.
elaxation time [26]. In this report, myocardial ischemia was
losely related to left ventricular systolic and diastolic dysfunction
n patients with hypertension. Therefore, we may  speculate that
ncreased EAT may  deteriorate diastolic function by decreasing
oronary ﬂow reserve due to secreted mediators which may  affect
yocardial tissue and coronary arteries either by endocrine effect
r by direct diffusion via vasa vasorum or by passive perivascular
ompressive and thermogenic effects even before clinically evident
schemia. In our study, since we found a moderate independent
orrelation between EAT and diastolic dysfunction parameters, we
hink that EAT may  be a contributor rather than an absolute cause.
EAT is a source of several pro-inﬂammatory and pro-atherogenic
ytokines [27–29]. Our results showed a positive correlation
etween CRP levels and EAT. Previous studies demonstrated
ypertension-like changes in myocardial tissue cultures with
nterleukin 6 (IL-6) and transforming growth factor-,  cytokines
ecreted from EAT [30,31]. Additionally, mediators secreted from
AT may  inﬂuence collagen metabolism negatively by stimulat-
ng local inﬂammation [32]. We  think that EAT may  enhance
yocardial hypertrophy, myocardial ﬁbrosis, and perivascular
brosis. Although our study was not designed to investigate this
ssue, autopsy and echocardiographic ﬁndings in previous studies
emonstrated a strong association between EAT and left ventri-
ular hypertrophy [33,34]. Our analyses also showed a signiﬁcant
levation in thicknesses of interventricular septum and posterior
all with increasing EAT, thus supporting our theory.
Moreover, recent studies also documented that EAT is also asso-
iated with diastolic dysfunction, non-dipper status, increased left
trial size and lower ejection fraction, arterial stiffness, higher coro-
ary calcium score, and reduced regional systolic motion in various
opulations. Pathological changes within myocardium and perivas-
ular area may  cause diastolic dysfunction due to either impaired
oronary ﬂow reserve or myocardial stiffness [35–37].
We  also revealed a signiﬁcant association between EAT and
eft atrial volumes. The left atrium has a central role that involvesressure; CRP, C-reactive protein; LA, left atrium; LV, left ventricle; IVRT, isovolumic
collecting blood during systole and augmenting left ventricular
ﬁlling during diastole [38]. Left ventricular diastolic dysfunction
may  lead to left atrial pressure overload, which, if chronically
maintained, may  end in left atrial remodeling and enlargement
[39]. Left atrial diameter is independently associated with all-cause
mortality and ischemic stroke [40]. Since we excluded patients
with moderate-severe valvular disease, diastolic dysfunction is
likely to be the cause of left atrial enlargement that appears in
association with increased EAT [41].
Nelson et al. demonstrated a positive correlation between EAT
and Framingham risk score. They also revealed higher carotid
plaque burden in patients with EAT thickness >5.0 mm,  compared
to patients with EAT thickness <5.0 mm [42]. We  also investigated
this relationship between EAT and Framingham risk score and con-
ﬁrmed it in our study. We  also found similar correlations to left
atrial diameter and diastolic dysfunction parameters. We  believe
that EAT is not only a marker but also a factor for metabolic and
structural changes in myocardium and human body. Although EAT
may  not be the sole cause of diastolic dysfunction, it may be an
important contributor to it.
Study limitations
Our study has several limitations. Currently, MRI and non-
contrast cardiac CT [43] are the gold standard diagnostic methods
for assessing epicardial fat. By measuring epicardial fat thickness
and volumes, these methods provide more accurate assessment.
Although epicardial fat is readily visualized with high-speed
CT and MRI, widespread use of these methods for assess-
ment of EAT is not practical. Echocardiography provides an
objective, noninvasive, readily available method and is cer-
tainly less expensive than MRI  or CT for measuring epicardial
fat.
The relatively low number in the study population may  be a
limitation for interpretation of our results. We  implemented spe-
ciﬁc patient criteria to avoid potential confounders. In addition, we
speciﬁcally included untreated hypertensive patients in the early
stage of HT rather than patients with long-standing HT. This and
the low sample size of the current study might have resulted in
low correlations among study parameters.
Another limitation is that our study had a cross-sectional longi-
tudinal study design and a cohort study might provide information
for causality. The measurement of EAT and diastolic function
parameters by echocardiography may be a limitation because it
can facilitate an unconscious bias. To overcome this limitation,
two different sonographers blinded for the study details performed
measurements of EAT and extensive diastolic parameters sepa-Currently there is no gold standard method for determining
diastolic dysfunction. Therefore, we  evaluated several diastolic
parameters with extensive echocardiography parameters.
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In conclusion, an increased EAT thickness related to diastolic
ysfunction and left atrial enlargement in patients with essential
T. Based on our ﬁndings, increased EAT may  be associated with
iastolic dysfunction and left atrial dilatation due to local or sys-
emic effects in untreated hypertensive patients. This relationship
s independent of and stronger than abdominal obesity, implicat-
ng the clinical importance of measuring EAT thickness. Although
here is currently no treatment option for lowering EAT thickness,
atients with thinner EAT seem to have a lower risk of diastolic
ysfunction and a better prognosis.
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